Prosecution Insights
Prosecution Insights
5 pending office actions • 1 client • 4 examiners • 2 art units • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| §112 only | 2 (40%) |
| Double-patenting + other | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POLIAKOVA-GEORGAN, EKATERINA | 2 | 64.3% | +17.6% |
| CHONG, KIMBERLY | 1 | 72.4% | +12.6% |
| ZARA, JANE J | 1 | 70.8% | +16.1% |
| ANGELL, JON E | 1 | 70.9% | +21.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546462 | COMPOUNDS AND METHODS FOR REDUCING NLRP3 EXPRESSION | CHONG, KIMBERLY | 24d overdue |
| 17416108 | MODULATORS OF HSD17B13 EXPRESSION | ANGELL, JON E | 4d overdue |
| 18001848 | COMPOUNDS AND METHODS FOR MODULATING PMP22 | POLIAKOVA-GEORGAN, EKATERINA | 3d overdue |
| 18457941 | MODULATORS OF PNPLA3 EXPRESSION | POLIAKOVA-GEORGAN, EKATERINA | — |
| 17508516 | COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION | ZARA, JANE J | — |
| Client (Assignee) | Pending OAs |
|---|---|
| IONIS PHARMACEUTICALS, INC. | 5 |
| Art Unit | Apps |
|---|---|
| 1637 | 4 |
| 1636 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18457941 | MODULATORS OF PNPLA3 EXPRESSION | Ionis Pharmaceuticals, Inc. | POLIAKOVA-GEORGAN, EKATERINA | 1637 | DPOther | Non-Final OA | — | Pending | Aug 29, 2023 |
| 18546462 | COMPOUNDS AND METHODS FOR REDUCING NLRP3 EXPRESSION | Ionis Pharmaceuticals, Inc. | CHONG, KIMBERLY | 1636 | §112 | Non-Final OA | 24d overdue | Pending | Aug 15, 2023 |
| 18001848 | COMPOUNDS AND METHODS FOR MODULATING PMP22 | Ionis Pharmaceuticals, Inc. | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §103 | Non-Final OA | 3d overdue | Pending | Dec 14, 2022 |
| 17508516 | COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION | Ionis Pharmaceuticals, Inc. | ZARA, JANE J | 1637 | §103 | Non-Final OA | — | Pending | Oct 22, 2021 |
| 17416108 | MODULATORS OF HSD17B13 EXPRESSION | Ionis Pharmaceuticals, Inc. | ANGELL, JON E | 1637 | §112 | Final Rejection | 4d overdue | Pending | Jun 18, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial